Stock listing
NASDAQ:DOVA Dova Pharmaceuticals Inc Stock
Follow Dova Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:DOVA
$28.04 USD
Close on Nov 11, 2019 · No longer trades
- Lowest – highest close
- $5.73 – $34.71 USDSince Jun 29, 2017 · lowest Dec 20, 2018 · highest Feb 20, 2018
Delisted NASDAQ:DOVA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:DOVA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Dova Pharmaceuticals Inc on 6ix
- Decks
- 4 decks · latest Jan 7, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| J.P. Morgan 37th Annual Healthcare Conference 2019 | Conference | 19 slides | Jan 7, 2019 |
| Investor Presentation (October 2018) | Investor deck | 32 slides | Oct 2, 2018 |
| Corporate Update (May 2018) | Corporate update | 14 slides | May 21, 2018 |
| Technical Presentation (October 2017) | Technical | 24 slides | Oct 23, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Nancy J. Wysenski Other companies: Cytokinetics, Incorporated (Director · Since at least Nov 20, 2020); Provention Bio Inc (Director · May 19, 2020 – Apr 27, 2023 · Past); Inovio Pharmaceuticals, Inc. (Director · Mar 4, 2015 – May 13, 2016 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 10, 2014 – Jun 10, 2019 · Past); Alkermes plc (Director · May 15, 2013 – Jul 7, 2023 · Past); Vertex Pharmaceuticals Incorporated (EVP, Chief Commercial Officer · Dec 9, 2009 – May 14, 2012 · Past); Indevus Pharmaceuticals Inc (Director · Feb 23, 2009 – Feb 23, 2009 · Past); North American Scientific Inc (Director · May 3, 2006 – Apr 29, 2008 · Past) | Director · Jun 25, 2018 – Nov 12, 2019 · Past |
| David Zaccardelli Other companies: Vor Biopharma Inc. (Director · Since at least Jul 7, 2026); SAB Biotherapeutics, Inc. (Chair of the Board · Since at least Jan 5, 2026); Verona Pharma plc (President and CEO, Director · Since at least Jan 28, 2021); Melinta Therapeutics Inc (Director · May 29, 2018 – Jun 11, 2019 · Past); Cempra Inc (Acting Chief Executive Officer, Director · Aug 10, 2016 – Dec 9, 2016 · Past); United Therapeutics Corporation (EVP & Chief Operating Officer · Jan 1, 2015 – May 13, 2016 · Past) | President & CEO, Director · Dec 17, 2018 – Nov 12, 2019 · Past |
| Paul B. Manning Other companies: Candel Therapeutics, Inc. (Chair of the Board · Since at least Jul 26, 2021); Liquidia Corporation (Board Member · Since at least Nov 18, 2020); Verrica Pharmaceuticals Inc. (Chairman · Since at least Jun 14, 2018); Taysha Gene Therapies, Inc. (Director · Sep 23, 2020 – Oct 31, 2022 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); Perrigo Company plc (EVP & General Manager, PBM · Jun 9, 2010 – Jun 9, 2010 · Past) | Director · Jun 28, 2017 – Nov 12, 2019 · Past |
| Roger Jeffs Other companies: Liquidia Corporation (Chief Executive Officer · Since at least Nov 18, 2020); Axsome Therapeutics, Inc. (DIRECTOR · Since at least Nov 19, 2015); Sio Gene Therapies Inc (Director · Feb 8, 2018 – Apr 15, 2019 · Past); Albireo Pharma Inc (Director · Sep 27, 2017 – Jun 24, 2021 · Past); Sangamo Therapeutics, Inc. (Director · Jun 26, 2017 – Sep 7, 2018 · Past); United Therapeutics Corporation (President & Co-CEO, Director · Jan 5, 2006 – Mar 15, 2016 · Past) | Director · Jun 28, 2017 – Nov 12, 2019 · Past |
| Mark W Hahn Other companies: Soleno Therapeutics, Inc. (Director · Since at least Oct 13, 2025); Verona Pharma plc (Chief Financial Officer · Since at least Jan 1, 2021); ALSP Orchid Acquisition I Corp (Director · Nov 18, 2021 – Nov 18, 2021 · Past); Cempra Inc (EVP and CFO · Feb 2, 2012 – Feb 23, 2017 · Past) | Chief Financial Officer · Jan 31, 2018 – Nov 12, 2019 · Past |
| John A Stalfort III Other companies: Taysha Gene Therapies, Inc. (Director · Since at least Jun 22, 2023); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Verrica Pharmaceuticals Inc. (Director · Jun 14, 2018 – Nov 22, 2024 · Past) | Director · Jun 28, 2017 – Nov 12, 2019 · Past |
| Alex C. Sapir Other companies: Fulcrum Therapeutics, Inc. (President and Chief Executive Officer · Since at least Jul 1, 2023); PhaseBio Pharmaceuticals Inc (Director · Feb 12, 2020 – May 19, 2023 · Past) | President & CEO, Director · Jun 28, 2017 – Aug 14, 2018 · Past |
| Steven M Goldman Other companies: ConnectOne Bancorp, Inc. (Director · May 3, 2013 – Feb 4, 2014 · Past) | Director · Jun 28, 2017 – Nov 12, 2019 · Past |
| Douglas Blankenship | Chief Financial Officer · Jun 28, 2017 – Jun 28, 2017 · Past |
| Kevin Laliberte | Sr. VP, Product Development · Nov 6, 2017 – Nov 12, 2019 · Past |
Log in to ask 6ix AI your own questions about Dova Pharmaceuticals Inc.